Novo Nordisk to present phase 3 trials of hemophilia research at ISTH 2025

Return On Information New Jersey

Jun 9, 2025

Novo Nordisk announced that new hemophilia data will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Congress, June 21-25. Key data presenta…